Zymeworks (ZYME) Net Cash Flow Growth (1y) (2022 - 2026)
Zymeworks (ZYME) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Zymeworks | 1.76 Bn | 1.40 Bn | - | 1,911.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,911.96% |
| Dec 31, 2025 | 58.07% |
| Sep 30, 2025 | -165.17% |
| Jun 30, 2025 | 150.41% |
| Mar 31, 2025 | 123.54% |
| Dec 31, 2024 | -189.15% |
| Sep 30, 2024 | 207.55% |
| Jun 30, 2024 | -11.25% |
| Mar 31, 2024 | 80.49% |
| Dec 31, 2023 | -79.26% |
| Sep 30, 2023 | 53.52% |
| Jun 30, 2023 | 48.76% |
| Mar 31, 2023 | -397.78% |
| Dec 31, 2022 | 690.05% |